PAM
MIST icon

PVG Asset Management’s Milestone Pharmaceuticals MIST Stock Holding History

PVG Asset Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,345
Closed -$46.1K – 59
2024
Q3 		$46.1K Buy
+30,345
New +$44.2K 0.19% 42
2023
Q4 		$32.3K Buy
19,320
+3,915
+25% +$10.6K 0.16% 32
2023
Q3 		$47.8K Hold
15,405
– – 0.33% 22
2023
Q2 		$43.9K Sell
15,405
-430
-3% -$1.62K 0.19% 34
2023
Q1 		$62.4K Buy
+15,835
New +$57.9K 0.2% 34

Other funds holding MIST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $333M AUM 102.25% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

PVG Asset Management's MIST Position: Q4 2024 in Review

PVG Asset Management sold out of Milestone Pharmaceuticals (MIST) in Q4 2024, closing a stake of 30,345 shares — an estimated $46.1K sold.

PVG Asset Management first reported a position in MIST in Q1 2023 and held it in 5 quarters. The position peaked at $62.4K in Q1 2023. 47 funds tracked by Wall St. Rank hold MIST as of Q4 2024.

  • PVG Asset Management reported no remaining Milestone Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • PVG Asset Management sold 30,345 Milestone Pharmaceuticals shares in Q4 2024, an estimated $46.1K.
  • PVG Asset Management first reported a position in Milestone Pharmaceuticals in Q1 2023 and held it in 5 quarters.
  • PVG Asset Management's Milestone Pharmaceuticals position peaked at $62.4K in Q1 2023.
  • 47 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q4 2024.

Based on PVG Asset Management's 13F filing for Q4 2024, filed 21 Feb 2025.